Availability of transcatheter repair of aortic stenosis benefits patients
Tuesday, January 28, 2014 - 13:30
in Health & Medicine
The introduction of minimally invasive transcatheter aortic valve replacement (TAVR) for treatment of aortic stenos not only has increased the number of patients eligible for aortic valve replacement (AVR), but also has led to a decrease in patient mortality, suggesting that patients fare better when multiple treatment options are available.